If your pharmaceutical maker has lots of suppliers, then these suppliers must also be assessed by classifying them into different stages dependent on their own effect on the medicinal product.Has the validation or product progress staff determined the classification of the raw materials? Why or why not?Lonza is Furthermore looking into launching em